Photodynamic therapy for cancers: a clinical trial of porfimer sodium in Japan.
Photodynamic therapy utilizing Photofrin has proven to be an effective modality that can be used in the treatment of a wide variety of solid tumors and luminal cancers. An argon pumped dye laser or excimer dye laser was used to deliver 630 nm light via quartz fibers passed through the biopsy channel subsequent to i.v. injection of photosensitizer. In this study, 64 patients with superficial cancers were treated in this manner but only 58 patients, including 21 with roentgenographically occult lung cancer, 8 with stage I lung cancer, 5 with esophageal cancer, 12 with gastric cancer, 8 with cervical cancer and 4 with bladder cancer were evaluable. Complete remission was obtained in 48 out of 58 cases (82.8%). There was no serious complication except skin photosensitivity, which was seen in 13 patients. We conclude that photodynamic therapy is efficacious in the treatment of superficial cancers where complete remission may be achieved.
Kato
H
H
Department of Surgery, Tokyo Medical College.
Horai
T
T
Furuse
K
K
Fukuoka
M
M
Suzuki
S
S
Hiki
Y
Y
Ito
Y
Y
Mimura
S
S
Tenjin
Y
Y
Hisazumi
H
H
D000328:Adult; D000368:Aged; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D005260:Female; D017324:Hematoporphyrin Derivative / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D010778:Photochemotherapy / Q000009:adverse effects / Q000379:methods*
D017324:Hematoporphyrin Derivative; D017323:Dihematoporphyrin Ether